Aviva
CRMD icon

Aviva’s CorMedix CRMD Stock Holding History

Aviva’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
51,088
-14,402
-22% -$114K ﹤0.01% 806
2026
Q1 		$445K Buy
65,490
+19,425
+42% +$144K ﹤0.01% 738
2025
Q4 		$536K Buy
46,065
+8,035
+21% +$88.8K ﹤0.01% 713
2025
Q3 		$442K Buy
+38,030
New +$460K ﹤0.01% 833

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aviva's CRMD Position: Q2 2026 in Review

Aviva reduced its CorMedix (CRMD) stake by 22% in Q2 2026, selling an estimated $114K and leaving 51,088 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Aviva first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $536K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Aviva held 51,088 shares of CorMedix worth $401K as of Q2 2026.
  • Aviva sold 14,402 CorMedix shares in Q2 2026, an estimated $114K.
  • CorMedix made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #806 holding.
  • Aviva first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Aviva's CorMedix position peaked at $536K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.